{"product_id":"peripheral-vascular-devices-market-analysis-size-trends-europe-2023-2029-medsuite-includes-peripheral-vascular-stent-market-stent-graft-market-transcatheter-embolization-market-15-more","title":"Peripheral Vascular Devices Market Analysis, Size, Trends - Europe - 2023-2029 - MedSuite - Includes: Peripheral Vascular Stent Market, Stent Graft Market,Transcatheter Embolization Market \u0026 15 more","description":"\u003cp\u003ePeripheral Vascular Devices Market Analysis, Size, Trends - Europe - 2023-2029 - MedSuite - Includes: Peripheral Vascular Stent Market, Stent Graft Market,Transcatheter Embolization Market \u0026amp; 15 more\u003cbr\u003e\nIn 2022, the European market for peripheral vascular devices reached a valuation of approximately €1.5 billion. As we look ahead, it is expected to experience a steady growth rate with a projected CAGR of 3.1% during the forecast period, ultimately reaching around €1.9 billion.\u003c\/p\u003e\n\n\u003cp\u003eOur extensive medical device market research encompassed an analysis of over 50 companies operating within the peripheral vascular device market across Europe. Through our comprehensive methodology, we delved into various aspects including market sizes, unit sales, company market shares, and average sales prices (ASPs) to provide accurate forecasts.\u003c\/p\u003e\n\n\u003cp\u003eThe full report suite on the European peripheral vascular (PV) devices market offers a comprehensive analysis of a wide range of devices including peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy (IVL) systems, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, carotid shunts, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices, and peripheral intravascular ultrasound (IVUS) catheters. Our in-depth analysis provides valuable insights into this dynamic market.\u003c\/p\u003e\n\n\u003cp\u003eDATA TYPES INCLUDED\u003c\/p\u003e\n\n\u003cp\u003eUnit Sales, Average Selling Prices, Market Value \u0026amp; Growth Trends\u003cbr\u003e\nForecasts Until 2029, and Historical Data to 2019\u003cbr\u003e\nMarket Drivers \u0026amp; Limiters for Each Peripheral Vascular Device market\u003cbr\u003e\nCompetitive Analysis with Market Shares for Each Segment\u003cbr\u003e\nRecent Mergers \u0026amp; Acquisitions\u003cbr\u003e\nDisease Overviews and Demographic Information\u003cbr\u003e\nCompany Profiles, Product Portfolios and SWOT for Top Competitors\u003c\/p\u003e\n\n\u003cp\u003eEUROPEAN PERIPHERAL VASCULAR DEVICES MARKET INSIGHTS\u003c\/p\u003e\n\n\u003cp\u003eThe COVID-19 pandemic had a significant impact on the European peripheral vascular (PV) market in 2020. Lockdown measures and procedure delays led to reduced demand and lower sales for PV device companies. However, as restrictions eased and procedures resumed, the PV market started to recover. In 2021 and 2022, there was a noticeable increase in demand for PV devices as postponed procedures were addressed. This recovery demonstrates the resilience of the PV market in Europe.\u003c\/p\u003e\n\n\u003cp\u003eThe IVL (Intravascular Lithotripsy) market in Europe has witnessed significant growth in recent years. This advanced technology employs sound waves to disrupt calcium deposits in arteries, offering a more effective and minimally invasive alternative to conventional treatments for peripheral arterial disease. The escalating prevalence of peripheral artery disease, coupled with the rising demand for less invasive treatment options, has fueled the increasing adoption of IVL in Europe.\u003c\/p\u003e\n\n\u003cp\u003eEUROPEAN PERIPHERAL VASCULAR DEVICES MARKET SHARE INSIGHTS\u003c\/p\u003e\n\n\u003cp\u003eIn 2022, Medtronic emerged as the leading player in the European PV market, leveraging its strong presence in the stent graft segment and diverse product portfolio. The company's ability to capture significant shares in high-value markets has enabled it to bundle lower-priced products, enhancing its overall market position. Medtronic's flagship offerings, such as Admiral IN.PACT™ drug-coated balloons, Endurant™ and Valiant™ stent grafts, along with a range of stents and PTA balloons, have contributed to substantial revenue generation. Furthermore, Medtronic has established dominance in the atherectomy device market, despite its relatively smaller size in Europe.\u003c\/p\u003e\n\n\u003cp\u003eCook Medical secured the second-leading position in the PV market, primarily driven by its strong foothold in the stent graft segment. The company also led the inferior vena cava filter (IVCF) market, although it constitutes a smaller portion of its revenue due to the market's size. Cook Medical's Zenith® family of stent grafts stands out as the company's flagship product, contributing significantly to its overall market presence.\u003c\/p\u003e\n\n\u003cp\u003eBoston Scientific, following its merger with BTG in 2019, initially secured the second-leading position in the European market. However, in 2022, it slipped to the third position due to market share loss to Cook Medical. Nevertheless, Boston Scientific has made notable progress in its venous treatment and transcatheter embolization portfolios after the acquisition, establishing a leading position in both markets. With a comprehensive portfolio for treating venous diseases, Boston Scientific is expected to gradually regain market share in the overall PV market over time.\u003c\/p\u003e\n\n\u003cp\u003eRESEARCH REGIONAL COVERAGE\u003c\/p\u003e\n\n\u003cp\u003eThroughout our research series, iData Research has extensively covered numerous countries, providing in-depth analysis and insights. Some of the countries we have focused on include:\u003c\/p\u003e\n\n\u003cp\u003eGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nU.K.\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nBenelux (Belgium, Netherlands, and Luxembourg)\u003cbr\u003e\nSwitzerland\u003cbr\u003e\nAustria\u003cbr\u003e\nPortugal\u003cbr\u003e\nScandinavia (Denmark, Finland, Norway and Sweden)\u003c\/p\u003e\n\n\u003cp\u003eSEGMENTS COVERED\u003c\/p\u003e\n\n\u003cp\u003ePeripheral Vascular Stent Market\u003cbr\u003e\nPTA Balloon Catheter Market\u003cbr\u003e\nDrug-Coated Balloon Market\u003cbr\u003e\nAtherectomy Device Market\u003cbr\u003e\nIntravascular Lithotripsy Market\u003cbr\u003e\nCTO Device Market\u003cbr\u003e\nSurgical Graft Market\u003cbr\u003e\nStent Graft Market\u003cbr\u003e\nEmbolic Protection Device Market\u003cbr\u003e\nPeripheral Thrombus Management Market\u003cbr\u003e\nInferior Vena Cava Filter Market\u003cbr\u003e\nCarotid Shunt Market\u003cbr\u003e\nDiagnostic and Interventional Catheter Market\u003cbr\u003e\nDiagnostic and Interventional Guidewire Market\u003cbr\u003e\nIntroducer Sheath Market\u003cbr\u003e\nVascular Closure Device Market\u003cbr\u003e\nTranscatheter Embolization Market\u003cbr\u003e\nPeripheral IVUS Market\u003c\/p\u003e\n\n\u003cp\u003eRESEARCH SCOPE SUMMARY\u003c\/p\u003e\n\n\u003cp\u003eRegions: Western Europe, Central \u0026amp; Eastern Europe\u003cbr\u003e\nBase Year: 2022\u003cbr\u003e\nForecast: 2023-2029\u003cbr\u003e\nHistorical Data: 2019-2022\u003c\/p\u003e\n\n\u003cp\u003eQuantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.\u003c\/p\u003e\n\n\u003cp\u003eQualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis \u0026amp; SWOT for Top Competitors, Mergers \u0026amp; Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.\u003c\/p\u003e\n\n\u003cp\u003eData Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import \u0026amp; Export Data, iData Research Internal Database.\u003c\/p\u003e\n\n\u003cp\u003eWHY CHOOSE IDATA?\u003c\/p\u003e\n\n\u003cp\u003eExperts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.\u003c\/p\u003e\n\n\u003cp\u003eAttention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"June, 2023 \/ 1041 Pages \/ MCW16245508","offer_id":47662710030642,"sku":null,"price":10794.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/peripheral-vascular-devices-market-analysis-size-trends-europe-2023-2029-medsuite-includes-peripheral-vascular-stent-market-stent-graft-market-transcatheter-embolization-market-15-more","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}